ABBV · XBRL financial data

AbbVie financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (ABBV's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue14,30112,31014,46214,46015,10213,34315,42315,77616,61815,00216,99017,404
Revenue from contracts with customersyear only———year only———year only———
Cost of goods and services sold5,704*4,0944,2024,2124,396*4,0024,3465,3044,552*4,2184,2914,285
Gross profit8,597———10,706———12,066———
Selling, general and administrative3,193*3,3153,3774,2053,855*3,2933,2533,5693,895*3,5783,6324,087
Other operating income (expense)0*0007*—240217*—018
Operating income (loss)3,195*2,7983,9983,831(1,490)*3,7334,8941,9044,544*3,9906,4326,267
Interest income—207220129—736272—7267102
Interest expense564*660726720702*700740739714*717746802
Other income (expense)(1,556)*(586)(1,345)(1,159)(150)*(1,441)(2,639)(503)(1,210)*(2,306)(1,475)(738)
Income tax expense (benefit)388*383773520(2,246)*372613526853*342662609
Net income (loss)8221,3691,3701,561(22)1,2869381861,8166953,6134,218
Earnings per share, basic USD per share0.460.770.770.88(0.02)0.720.520.101.020.392.042.38
Earnings per share, diluted USD per share0.460.770.770.88(0.02)0.720.520.101.020.392.032.37
Weighted average shares, basic millions of shares1,768*1,7691,7681,7691,770*1,7681,7681,7691,771*1,7701,7691,769
Weighted average shares, diluted millions of shares1,774*1,7731,7711,7721,776*1,7721,7711,7721,777*1,7741,7711,772

Balance sheet

CSV

Fiscal quarters (ABBV's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents12,81418,06713,1307,2575,5245,1756,4675,6295,2299,3916,56910,774
Short-term investments22272831104228———
Accounts receivable11,15511,94911,72411,47210,91912,47712,63712,76912,58912,47913,82413,509
Inventory4,0994,2454,2184,4504,1814,5264,9604,9384,9515,0495,1275,305
Prepaid and other current assets————————6,293—8,1497,892
Total current assets33,00238,87133,81627,78525,58227,67529,26128,53929,06233,52933,66937,480
Property and equipment, net4,9894,9805,0235,1415,1345,2375,2835,4835,6285,6875,7965,941
Right-of-use asset744———723———737———
Goodwill32,29333,42633,38635,29534,95635,28535,63835,62635,64035,57035,51937,800
Total assets134,711148,874141,937143,422135,161136,165137,182133,898133,960136,463135,115147,680
Accounts payable3,688———2,945———3,592———
Total current liabilities37,84141,52241,91543,06238,74936,40339,76739,39143,28942,10041,64243,102
Lease liability, non-current735———697———689———
Accumulated deficit(1,000)(2,384)(3,768)(4,964)(7,900)(9,527)(11,503)(14,234)(15,493)(17,872)(17,333)(16,190)
Total stockholders' equity10,3608,0076,7786,0323,3251,420(183)(2,642)(3,270)(6,656)(5,935)(4,583)
Total liabilities and equity134,711148,874141,937143,422135,161136,165137,182133,898133,960136,463135,115147,680
Common shares outstanding (cover page) millions of shares1,7661,7661,7661,7671,7651,7661,7671,7671,7681,7671,7671,768

Cash flows

CSV

Fiscal quarters (ABBV's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)8221,3691,3701,561(22)1,2869381861,8166953,6134,218
Stock-based compensation125*348218*181*164*410179*209*157*444166*160*
Net cash from operating activities4,753*4,0402,271*5,447*7,048*1,6355,153*7,024*5,218*3,8293,436*7,606*
Purchases of property and equipment205*193241*249*291*235269*381*329*265322*301*
Net cash from investing activities(800)*(9,588)(1,102)*(8,256)*(1,874)*(735)(1,181)*(3,264)*(1,463)*(574)(1,197)*(10,215)*
Share repurchases3*1,3249*17*358*96112*4*3*1,4899*5*
Dividends paid2,626*2,7722,750*2,751*2,752*2,9252,910*2,911*2,911*3,0863,070*3,071*
Proceeds from long-term debt—14,9630*0*2,000*3,9940*0*0*7,9910*9,983*
Net cash from financing activities(4,449)*10,819(6,097)*(3,072)*(6,861)*(1,258)(2,710)*(4,590)*(4,166)*919(5,054)*6,820*
Net change in cash(473)*5,253(4,937)*(5,873)*(1,733)*(349)1,292*(838)*(400)*4,162(2,822)*4,205*

Compare with peers

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.